Sysmex ADR EPS - Earnings per Share 2016-2024 | SSMXY

Sysmex ADR earnings per share (EPS) for the twelve months ending June 30, 2024 was $0.31, a 30.2% decline year-over-year.

  • Sysmex ADR EPS for the quarter ending June 30, 2024 was $0.11, a 22.07% decline year-over-year.
  • Sysmex ADR 2024 annual EPS was $0.53, a 2.78% decline from 2023.
  • Sysmex ADR 2023 annual EPS was $0.54, a 13.6% decline from 2022.
  • Sysmex ADR 2022 annual EPS was $0.63, a 31.03% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Sysmex ADR EPS - Earnings per Share 2016-2024 | SSMXY

  • Sysmex ADR EPS for the quarter ending June 30, 2024 was $0.11, a 22.07% decline year-over-year.
  • Sysmex ADR 2024 annual EPS was $0.53, a 2.78% decline from 2023.
  • Sysmex ADR 2023 annual EPS was $0.54, a 13.6% decline from 2022.
  • Sysmex ADR 2022 annual EPS was $0.63, a 31.03% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$194.7B
Intuitive Surgical (ISRG)$191.9B
Alcon (ALC)$42.1B
Edwards Lifesciences (EW)$41.4B
IQVIA Holdings (IQV)$34.7B
IDEXX Laboratories (IDXX)$34.1B
DexCom (DXCM)$29.2B
STERIS (STE)$20.9B
Waters (WAT)$20.5B
SONOVA HOLDING (SONVY)$20.3B
Hologic (HOLX)$18.2B
Fresenius Medical Care AG KGaA (FMS)$13B
Globus Medical (GMED)$11.3B
Penumbra (PEN)$9.1B
Teleflex (TFX)$9B
Masimo (MASI)$8.8B
Glaukos (GKOS)$8B
PROCEPT BioRobotics (PRCT)$4.9B
Integer Holdings (ITGR)$4.5B
Veracyte (VCYT)$3B
Inari Medical (NARI)$3B
LivaNova (LIVN)$2.8B
TransMedics (TMDX)$2.8B
Nihon Kohden (NHNKY)$2.3B
Elekta AB (EKTAY)$2.2B
Tandem Diabetes Care (TNDM)$1.8B
RxSight (RXST)$1.8B
Integra LifeSciences Holdings (IART)$1.8B
Alphatec Holdings (ATEC)$1.4B
Artivion (AORT)$1.1B